|Home | About | Journals | Submit | Contact Us | Français|
Conceived and designed the experiments: MC JW DK. Performed the experiments: MC PM JW. Analyzed the data: MC JW DK. Contributed reagents/materials/analysis tools: MC PM JW DK. Wrote the paper: DK.
The Drosophila mutant loechrig (loe) shows age-dependent degeneration of the nervous system and is caused by the loss of a neuronal isoform of the AMP-activated protein kinase (AMPK) γ-subunit (also known as SNF4Aγ). The trimeric AMPK complex is activated by low energy levels and metabolic insults and regulates multiple important signal pathways that control cell metabolism. A well-known downstream target of AMPK is hydroxyl-methylglutaryl-CoA reductase (HMGR), a key enzyme in isoprenoid synthesis, and we have previously shown that HMGR genetically interacts with loe and affects the severity of the degenerative phenotype. Prenylation of proteins like small G-proteins is an important posttranslational modification providing lipid moieties that allow the association of these proteins with membranes, thereby facilitating their subsequent activation. Rho proteins have been extensively studied in neuronal outgrowth, however, much less is known about their function in neuronal maintenance. Here we show that the loe mutation interferes with isoprenoid synthesis, leading to increased prenylation of the small GTPase Rho1, the fly orthologue of vertebrate RhoA. We also demonstrate that increased prenylation and Rho1 activity causes neurodegeneration and aggravates the behavioral and degenerative phenotypes of loe. Because we cannot detect defects in the development of the central nervous system in loe, this suggests that loe only interferes with the function of the RhoA pathway in maintaining neuronal integrity during adulthood. In addition, our results show that alterations in isoprenoids can result in progressive neurodegeneration, supporting findings in vertebrates that prenylation may play a role in neurodegenerative diseases like Alzheimer’s Disease.
The loechrig (loe) mutant was isolated in a screen for mutants that show progressive neurodegeneration of the adult central nervous system. Whereas the brains of newly eclosed loe flies show no obvious defects, they begin to display spongiform lesions within all brain regions after a few days of adult life . These lesions increase with further aging and are accompanied by neuronal cell death, ultimately leading to the early death of loe flies after about three to four weeks. The loe gene encodes the γ-subunit of AMP-activated protein kinase (AMPK), a complex consisting of the catalytic α-subunit and the two regulatory subunits β and γ. The latter contains the binding sites for AMP thereby regulating the activation of the complex , . The mutation in loe is caused by the insertion of a P-element and affects only one alternative splice form that is strongly expressed in the nervous system . The protein isoform encoded by this transcript contains a unique N-terminus not shared by any of the other isoforms and only this isoform can rescue the loe phenotype when expressed in neurons, confirming the requirement of this specific isoform for the integrity of the nervous system . AMPK has been primarily studied as a regulator of energy homeostasis but recently it has been implicated in a plethora of other cellular functions including maintenance of cell polarity and insulin signaling . Whereas vertebrates have several genes for each subunit, flies contain only a single gene for each subunit, greatly facilitating a genetic analysis of AMPK’s function in Drosophila. Mutations in the fly α-subunit are lethal and show defects in mitosis and cell polarity as well as stress-induced abnormalities in the actin cytoskeleton , . alicorn mutants, which affect the β-subunit are also lethal but clonal analyses in the adult revealed a progressive degeneration  which together with the loe mutation suggests a role of AMPK in neuronal survival. Although the data are sparse and contradictory, a neuroprotective role of AMPK in vertebrates was suggested by the activation of AMPK in several models of pathological stress situations like cerebral ischemia and stroke . In addition, a mutation in PRKAG2, the γ2 isoform of human AMPK, can lead to Wolff-Parkinson-White syndrome, which causes hypertrophic cardiomyopathy and arrhythmia .
One of the well-known targets of AMPK is hydroxymethylglutaryl-CoA reductase (HMGR), the rate-limiting enzyme in cholesterol synthesis . Although the function of AMPK as a negative regulator of HMGR is conserved in Drosophila , this pathway is not involved in cholesterol synthesis in flies because they lack several enzymes required for the de novo synthesis of cholesterol . However, HMGR also regulates isoprenoid synthesis, a pathway that is conserved in insects . Mevalonate, the product of HMGR, can be converted into farnesyl-diphosphate and geranylgeranyl-diphosphate which provide, among other functions, covalently bound lipid moieties for the isoprenylation of membrane-targeted proteins . One class of proteins, known to be regulated by prenylation are GTPases like Ras, Rab, Rac, and Rho, resulting in their association with membranes and subsequent activation . The Rho family of GTPases comprises a major branch of the Ras superfamily and like Ras, Rho proteins function as GTP/GDP switches and alternate between an active GTP-bound state and an inactive GDP-bound state . Due to their role in actin polymerization, Rho-GTPases affect many functions of the cellular cytoskeleton depending on the cell type. Although changes in the actin cytoskeleton have been connected with neuronal survival and neurodegenerative diseases much less is known about the role of prenylation in this process. Promoting prenylation by adding geranylgeranyl-diphosphate (GGPP) resulted in increased levels of Aβ peptides  which accumulate in the plaques characteristic for Alzheimer’s Disease. In addition, it was shown that statins, known inhibitors of HMGR, can affect Aβ production by facilitating the non-amyloidogenic β-processing instead of the alternative β-processing that leads to Aβ production , . Statin treatment has also been used to investigate the role of prenylation in neurite outgrowth however the results have been inconsistent. Whereas some groups have reported that statin treatment promotes neurite outgrowth, others describe an inhibiting effect . At least in part, these controversial results might be due to the use of different cell lines and/or statins. In flies, statin treatment has been shown to decrease isoprenylated Ras and Rab4, accompanied by an increase in lifespan and an improvement in cardiac health .
Here we show that the loe mutation affects the regulatory function of AMPK on isoprenoid synthesis, leading to increased RhoA prenylation and progressive neurodegeneration.
As previously shown, flies homozygous for loe and heterozygous for lethal alleles of HMGR, which in Drosophila is encoded by the columbus gene , show a suppression of the degenerative phenotype compared to loe alone . These experiments confirmed that the inhibitory function of AMPK on HMGR is conserved in flies and that changes in the activity of HMGR play a role in the observed degenerative phenotype. HMGR is a key factor in cholesterol synthesis but also in isoprenoid synthesis, a pathway conserved in Drosophila (Fig. 1A). To specifically interfere with the isoprenoid pathway, we crossed loe with flies carrying mutations in the farnesyl diphosphase synthase (fpps) gene. FPPS is catalyzing the steps to produce geranyl-pyrophosphate and farnesyl-pyrophosphate that are subsequently used to provide the farnesyl and geranylgeranyl moieties attached to target proteins. For this experiment, we compared loe flies and loe flies that also carried a mutation in fpps. The loe control flies were obtained from the same cross but carried the CyO balancer instead of the fpps mutations to minimize genetic background effects. Analyzing head sections from five day old female flies homozygous for loe (Fig. 1B) with age-matched flies that in addition carry one mutant copy of the fppsk03514 (Fig. 1C) or fppsk06103 allele  revealed a significant suppression of the degenerative phenotype. Measuring the area of vacuoles in these flies in the optic system, we found a reduction from 163±24.5 µm2 in loe alone to 33±8.9 µm2 and 25±3.4 µm2 in loe carrying one copy of fppsk03514 or fppsk06103 (Fig. 1D; p<0.001). Similarly, loe flies showed a reduction in the number of vacuoles from 5±0.6 to 3.3±0.5 and 3.1±0.4 when also one copy of fpps was mutant, confirming an involvement of the isoprenoid pathway in the degenerative phenotype of loe. Wild type flies, heterozygous fppsk03514 mutants, or heterozygous loe mutants showed no degenerative phenotype with only occasionally a small vacuole forming (Fig. 1D and 1E). Due to the lethality of homozygous mutant fpps flies during development these could not be analyzed as adults.
In addition to these genetic experiments, we performed pharmacological manipulations using farnesol and geranyl-geraniol to increase isoprenylation. Whereas we did not detect an effect of farnesol, feeding geranyl-geraniol in 5% glucose enhanced the degeneration in seven day old loe flies from 317±89 µm2 to 1402±233 µm2 (p<0.001; Fig. 2A). Similarly, the number of vacuoles was increased from 4.8±1.2 to 10.4±1.7 in the treated loe flies (p<0.05; Fig. 2B) further supporting a role of altered isoprenoid levels in the degeneration observed in loe. In addition, we tested whether feeding geranyl-geraniol can induce degeneration in wild type flies and as shown in Figure 2C, we found significant vacuolization in wild type flies treated for seven days with 10 mM geranyl-geraniol compared to untreated controls. Whereas control showed only a few (0.5±0.2), very small vacuoles (3±1.133 µm2), treated wild type flies had an average of 6±0.9 vacuoles with a total area of 146±21.2 µm2 (both p values <0.0001). These results strongly suggest that an increase in isoprenoid production can lead to a neurodegenerative phenotype.
As pointed out above, small GTPases are well known targets of isoprenylation and we therefore investigated whether loe genetically interacts with mutations in Rho-GTPases. Whereas we could not detect any significant effects of removing one copy of cdc42 or Rab5 in loe (215±17 µm2 and 174±22 µm2 versus 182±29 µm2) heterozygosity for Rho1, the fly orthologue of vertebrate RhoA, resulted in a suppression of the vacuolization. Combining one copy of Rho72F, an allele that deletes part of the coding region including the translation start site , with loe (Fig. 3B) reduced the vacuolization almost by half in 5 d old flies with 117±16 µm2 compared to 208±21 µm2 in control loe flies (Fig. 3A, 3D; p<0.001). In addition, we used a constitutively active form of Rho1 (RhoV14;  to determine whether increased Rho activity can aggravate the degeneration in loe. As shown in Figure 3C and 3D, expression of this construct in the nervous system, using a pan-neuronal Appl-GAL4 promoter line enhanced the degeneration to 338±29 µm2 (p<0.01). Neither heterozygous Rho72F flies, nor Appl-GAL4;UAS-RhoV14 flies showed significant vacuolization at this age (9.5±2.7 and 11.0±3.3 µm2, respectively). Counting the number of vacuoles in these flies (Fig. 3E) also revealed a significant reduction when loe is heterozygous mutant for Rho72F with 5.4±0.4 compared to 3.0±0.5 (p<0.01) but although the number was increased in loe flies expressing the constitutive active Rho, the difference was not quite statistically significant (6.7±0.6; p=0.08).
To complement these data, we also investigated whether Rho levels affect the behavioral phenotype and lifespan of loe. Indeed, heterozygosity for Rho72F increased the performance index of loe flies in the fast phototaxis assay (36.7±4.1 to 55.1±3.2, Fig. 3F) whereas expression of RhoV14 via Appl-GAL4 decreased it significantly (to 10.6±5.2). Heterozygous Rho72F flies alone performed quite well however, Appl-GAL4;UAS-RhoV14 alone performed even worse than loe with 17.8±6.3 although these flies do not reveal significant vacuolization at this age (see Fig. 3E and 3F). Rho72F/+; loe/loe flies also showed a significant increase in lifespan compared to loe alone (p<0.001, Fig. 3G), confirming that heterozygosity for Rho also suppresses other deleterious phenotypes of loe. To finally verify a genetic interaction of Rho1 and loe, we used an RNAi construct that targets one of the common exons of loe. Inducing this construct pan-neuronally via elav-GAL4 did not result in a detectable degenerative phenotype in 14 d old flies (data not shown), however the flies revealed only a performance index of 48±4.1 in the fast phototaxis assay (Fig. 3H). Using this phenotype for a genetic interaction test also showed a suppression when Rho1 levels were reduced by heterozygosity for Rho72F and enhanced when constitutive active Rho1 was co-expressed (61.5±4.7 and 36.5±3.6; Fig. 3H). Finally, we tested whether we can induce a degenerative phenotype by the knockdown when increasing the number of drivers or by co-expressing dicer. As shown in Figure 3I, inducing the RNAi construct with elav-GAL4 and Appl-GAL4 did result in a degenerative phenotype in 14 d old flies similar to young loe mutants. A similar result was obtained by co-expression of dicer and the RNAi construct with Appl-GAL4 data not shown).
To confirm that our genetic manipulations did indeed affect the levels of Rho1, we performed Western Blots using an anti-Rho1 antibody. As expected, flies heterozygous for Rho72F showed a significant reduction in the levels of Rho1 compared to wild type flies (Fig. 4A, lane 1 and 2) whereas flies expressing constitutive active Rho1 (Rho1V14) in the nervous system revealed increased levels (Appl; c-Rho; lane 5). Surprisingly, we also found that loe flies showed a decrease in the levels of Rho1 (lane 3 and 4), suggesting that a compensatory mechanism exists that reduces the total levels of Rho1 when too much active Rho1 is present.
Although the effect of loe on the total amount of Rho1 protein was unexpected, we did expect that loe would affect the levels of prenylated Rho1. To confirm this, we immunoprecipitated Rho1 from head lysates using an anti-Rho1 antibody followed by Western Blots with an anti-farnesyl/geranylgeranyl antibody. As shown in Figure 4B, loe flies show increased levels of prenylated Rho1 (lane 2) whereas they are decreased in fppsk03514 heterozygous mutants (lane 3). That fppsk03514 mutants generally decrease the levels of isoprenylation is seen in the longer exposure in the input lane (lane 6) by the reduction of an unknown anti-farnesyl positive band (arrowhead, Gig. 4B). In contrast, this band appears not affected by loe (lane 5), suggesting that loe does not affect all prenylated proteins. Because the attachment of isoprenyl moieties facilitates membrane association of small GTPases, we also analyzed the membrane localization of Rho1 in wild type and loe flies. Comparing membrane and cytosolic fractions in Western Blots, we did indeed detect a slight increase in membrane associated Rho1 in loe (Fig. 5A, upper panel) together with a reduction in the levels of cytosolic Rho1 (Fig. 5B, upper panel). The efficiency of the fractionation of membranes and cytosol was confirmed by staining with an antibody against the membrane associated Cystein String Protein (Fig. 5A, lower panel) and the cytosolic Tubulin (Fig. 5B, lower panel). These experiments verify that loe mutants have more prenylated, membrane-associated Rho1.
Next we investigated whether a rise in active Rho1 can cause neurodegeneration in a wild type background. For this purpose, we expressed the constitutively active form pan-neuronally using Appl-GAL4. Although we did not detect vacuoles in young flies (5 d, see Fig. 3D, 3E), a few vacuoles were detectable in 14d old flies (arrows, Fig. 6B) in contrast to age-matched controls only carrying Appl-GAL4 which did not show any vacuoles (Fig. 6A). A quantification confirmed that the total size of vacuoles (24.6±6.7 µm2 versus 3.6±1.9 µm2; Fig. 6C) as well as their number (0.3±0.1 versus 1.1±0.2; Fig. 6D) was significantly increased in the Rho1V14 expressing flies compared to the controls.
Inducing the constitutive active Rho1V14 in the eye via GMR-GAL4 resulted in a much more dramatic degeneration already in young flies (Fig. 7D; 5 d old), probably due to the high expression levels of this promoter construct. As shown in Figure 7H, this phenotype already affects the development of the retina, causing a smaller and severely rough eye. To determine whether an increase in membrane association was sufficient to induce neurodegeneration, we created a Rho1 construct that carried an N-terminal myristyl group to promote its association with membranes. Expressing this construct in the nervous system using Appl-GAL4 did not result in a degenerative phenotype (data not shown), even when aged for 20 d. However, expressing it with the GMR-GAL4 driver in the eye resulted in a progressive degeneration of the retina. Whereas 5 d old GMR-GAL4/UAS-myr-Rho1 flies (Fig. 7B) were indistinguishable from control flies only expressing GMR-GAL4 (Fig. 7A) or only UAS-myr-Rho1 (data not shown), 30 day old GMR-GAL4/UAS-myr-Rho1 flies revealed several vacuoles in the retina (Fig. 7C, arrows). However, this did not affect the thickness of the retina, in contrast to the expression of the constitutive active Rho which resulted in a dramatic decrease of retinal thickness (17.2±1.6 µm compared to 60.8±1.5 µm in controls; Fig. 7E). Nevertheless the vacuole formation in myr-Rho1 expressing flies shows that facilitating the association of Rho1 with membranes is sufficient to induce degenerative effects.
To confirm that the Rho1 induced degeneration can is connected to loe, we performed genetic interaction tests using the rough eye phenotype induced by expression of Rho1V14 with GMR-GAL4. Though loe flies alone have a slightly rough eye (Fig. 7A), loe had no detectable effect on the external or internal phenotype caused by Rho1V14 (data not shown). However, overexpression of LOE, which by itself has a normal looking eye (Fig. 7G), suppressed the degeneration caused by Rho1V14 (compare Fig. 7H and 7I). This suggests that decreased isoprenylation of Rho1V14, by inhibition of the isoprenoid synthesis pathway through LOE, reduces its membrane association thereby affecting its interaction with its partners.
Since its first mention in 1973 , AMPK has developed into an key regulator of multiple biochemical pathways . In its role as a “stress sensor”, AMPK inhibits such energy demanding processes like cholesterol synthesis by inhibiting hydroxymethylglutaryl (HMG)-CoA reductase, the rate-limiting enzyme in cholesterol synthesis . Though the function of AMPK as a negative regulator of HMGR and most of the downstream biosynthetic pathway from mevalonate is conserved in flies , they cannot synthesis cholesterol de novo. This is due to the fact that they miss several of the downstream enzymes required for the synthesis of cholesterol from farnesyl pyrophosphate . However, flies have all the enzymes required to produce farnesyl pyrophosphate and geranylgeranyl pyrophosphate. Although, prenylation provides an important mechanism to regulate proteins, including neuronal proteins, the effects of changes in prenylation on neuronal outgrowth, function, and maintenance have not been well studied. Studies that have addressed this issue have mostly used statin treatment as a tool to affect isoprenylation and have provided mixed results. Statin treatment can promote or decrease neurite outgrowth depending on the used cell line, cell type, and/or the specific statin used in the experiment .
The loe mutant now allowed us to investigate how changes in isoprenoid synthesis can affect the nervous system without relying on pharmacological intervention. That the role of AMPK in regulating isoprenoid synthesis is involved in the progressive degeneration observed in loe was first confirmed by the genetic interaction with mutations in the farnesyl diphosphate synthase. Decreasing the expression of FPPS, significantly reduced the vacuole formation in loe supporting our hypothesis that the loss of functional neuronal AMPK upregulates the synthesis of isoprenoids. That an increase in these isoprenoid intermediates is deleterious for the nervous system was also supported by feeding geranyl geraniol which not only enhanced the degenerative phenotype in loe but also induced lesion in wild type flies.
As mentioned above, farnesyl pyrophosphate and geranylgeranyl pyrophosphate provide lipid moieties that are irreversible attached to the C-terminus of proteins, including small GTPases like Rho proteins, allowing their association with membranes . The targeting to membranes is then thought to facilitate their interaction with guanine nucleotide exchange factors leading to their activation . We therefore tested, whether the effects of changes in isoprenylation might be mediated by one of these proteins. As shown in Figure 3, manipulating the levels of Rho1, the fly RhoA, did indeed aggravate or ameliorate the degeneration and behavioral deficits in loe. In contrast, mutations in cdc42 or Rab5 did not modify the loe phenotype, which together with the result that some proteins did not show increased isoprenylation in loe suggests a certain specificity, possibly due to the restricted expression pattern of loeI to neurons. However, the reduction in Rho1 had less of a suppressing effect than the decrease in FPPS (about 50% with Rho compared to about 80% with FPPS), indicating that increased farnesylation of other proteins besides Rho1 also plays a role in the degenerative phenotype of loe.
As expected by the inhibitory function of AMPK on isoprenoid synthesis, reducing the levels of Rho1 was beneficial whereas further increasing the amount of active Rho1 by expressing a constitutive active form enhanced the phenotypes. We also confirmed that loe flies accumulate isoprenylated Rho1 and show, a slight increase in membrane associated Rho1. Interestingly, we also observed a decrease in the total levels of Rho1 in loe mutant flies, indicating that some feed-back mechanism exists that connects the levels of prenylated active Rho1 with Rho1 transcription or degradation. That an increase in membrane association and activation of Rho1 is sufficient to induce neurodegenerative phenotypes was confirmed by the results that expression of myristylated or constitutive active Rho1 also resulted in progressive degeneration, whereby the constitutive active Rho1 had more severe effects. However, in both cases the neurodegneration was not as severe as in loe, suggesting that the phenotype in this mutant is due to a pleitropic effect, consistent with the involvement of AMPK in a variety of other pathways.
RhoA has been extensively studied in neuronal development, whereby its activation has generally been connected with growth cone collapse and axon retraction , . However, in some instances it can also promote neurite outgrowth . As published previously , , we could not detect defects in the brains of 1st instar larvae or newly eclosed adult loe flies, suggesting that embryonic as well as pupal development of the central nervous system is not affected in this mutant. This is probably due to the fact that the loeI transcript, which is the only one affected by the mutation, is not or only very weakly expressed during development . However, loe mutant flies have a slightly rough eye, although this mainly affects the pattern of the bristles and we did not detect effects on the photoreceptors, suggesting that it does play a role in late pupal development of the eye. In contrast, to the weak expression during development, loeI is strongly expressed in the adult head, therefore probably mostly interfering with the posttranscriptional regulation of Rho1 in the adult nervous system. This would also be in agreement with the fact that we did not observe an enhancing effect of the loe mutation on the rough eye phenotype caused by the expression of constitutive active Rho1. Alternatively, this phenotype is too severe to detect further enhancement by loe. Interestingly, induction of LOE in the eye did suppress this phenotype, presumably by decreasing the isoprenylation of the constitutive active Rho1 thereby interfering with its membrane localization and interaction with its nucleotide exchange factors. In addition to this developmental phenotype, our results also show a requirement of Rho1 for the integrity and survival of established neurons. This is shown be the results that expressing myristylated Rho1 in the eye causes a progressive degeneration and not a developmental defect and also the degenerative phenotype after pan-neuronal expression of the constitutive active Rho1 was only detectable in aged animals. Interestingly, RhoA prenylation and the activation of its downstream target ROCK have been connected with the metabolism of the Amyloid Precursor Protein and Alzheimer’s Disease , suggesting that the posttranslational regulation of RhoA by isoprenylation also plays a role for the integrity of the nervous system in vertebrates. In addition, it has been shown that changes in genes that encode proteins involved in prenylation can lead to rare diseases like Hutchinson syndrome, retinitis pigmentosa and cancer .
All fly stocks were maintained and raised under standard conditions at 25°C. Canton S was used as wild type control. The Appl-GAL4 line was kindly provided by L. Torroya (Universidad Autonoma de Madrid, Spain). The loe mutation is described in . fppsk03514, fppsk06103 , Rho72F , Rho1V14.Scer\UAS , and the RNAi line SNF4AγJF02060 were obtained from the Bloomington stock center. UAS-myr-Rho1 flies were created by attaching a myr-tag (kindly provided by M. Wehrli, OHSU) to the coding region of Rho1 and cloning it into pUAST  for P-element transformation using the BestGene Transgenic Service.
After eclosion flies were kept in empty plastic vials deprived of normal food sources and nutrition was provided in the form of 5% glucose solution with or without the compound of interest. A small piece of tissue was soaked in 500 µl glucose solution and added to the vialsin an open Eppendorf tube. Geranyl geraniol and farnesol (both obtained from Sigma) were used at 5 mM and 10 mM.
Paraffin sections were performed as described in . To quantify the vacuolization, we photographed sections that showed the entire optic system and the worst phenotype. For a double blind analysis, pictures were taken without knowing the genotype and numbered. The area of the vacuoles in the lamina, medulla, lobula, and lobula plate of each brain hemisphere was then calculated in Photoshop as total pixel number, converted into µm2, and the genotype determined . In addition, we counted the number of vacuoles in each picture. Thickness of retinae was measured using ImageJ. As controls for the crosses with loe, we used flies from the same cross, which did not carry the UAS construct and flies which had a balancer chromosome instead of the additional mutation to minimize effects by the genetic background. Statistics were done using GraphPad Prism and one-way ANOVA. A Student’s Neuman-Keuls test was used to identify the significantly when only two groups were compared.
Heads were prepared and fixed as described in , critical point dried and sputtered with a 16 nm layer of gold/palladium. They were then viewed at 10 kV using a FEI Quanta 200 scanning electron microscope.
Fast phototaxis assays were conducted in the dark using the countercurrent apparatus described by  and a single light source. A detailed description of the experimental conditions can be found in . Flies were starved overnight, but had access to water and were tested the following morning. Five consecutive tests were performed in each experiment with a time allowance of 6 seconds to make a transition towards the light and into the next vial. A minimum of eight independent tests with groups of 5–10 flies was used per genotype (groups of 3–6 flies were tested for experiment including Appl-GAL4; Rho1V14 because we did not obtain many of these flies and they also showed an increased lethality during the starving period). For the lifespan analysis, newly eclosed flies were collected and transferred to fresh vials every 4–5 d. ANOVA was applied to data sets to reveal significant differences. Flies were kept in groups of 5–8 flies and at least 5 groups were analyzed. Statistical analysis was done using the analysis for survival curves in GraphPad Prism.
Heads from 2–3 d old flies were homogenized as described in  and proteins separated on 12% SDS-PAGE gels and transferred using the Bio-Rad Mini Trans-Blot® Cell system. Proteins were transferred to Hybond membranes (Amersham Bioscienses). Primary antibodies against Rho1, Cystein String Protein, and Tubulin were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the Department of Biology, University of Iowa, and used at 1100 in TBST supplemented with 5% nonfat dry milk. The anti-farnesyl/geranyl antiserum was obtained from Abcam and used at 1200. Bands were visualized using horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch) at 11000 and the SuperSignal® West Pico chemiluminiscent substrate (ThermoScientific). At least three replicates were performed.
For immunoprecipitations approximately 500 fly heads were homogenized and Rho1 precipitated following the protocol in , using the anti-Rho antibody and Protein A/G Plus Agarose (Santa Cruz Biotechnology). Membrane and cytosolic fractions were prepared from the different genotypes following the protocol of Orgad et al. . Appl-GAL4 flies were used as controls due to their similar eye color to loe, minimizing effects caused by varying levels of eye pigment in the Bradford assays. Approximately 300 heads were used for each preparation, protein amounts were determined by Bradford assays  and 4 µg total protein loaded per lane.
Special thanks are due to Burkhard Poeck for critical reading of the manuscript.
This work was funded by National Institutes of Health grant P30NS061800, Alzheimer Forschung Initiative e. V. (www.alzheimer-forschung.de), Medical Research Foundation of Oregon (www.ohsu.edu/xd/about/foundation/…/medical-research-foundation), and the Oregon Tax Check-off program (on Aging & Alzheimer’s Disease Center - Oregon Partnership for …www.ohsu.edu/xd/research/centers…/tax-checkoff-giving.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.